What Does This Year’s World Cancer Research Day Signify?

World Cancer Research Day 2026 took place for the tenth time on September 24^th and this year the theme is ‘Advancing Cancer Research Together’, highlighting the importance of collective efforts and global collaboration.

This is particularly important for the field of oncology innovation, which is at the leading edge of new techniques, trials, and research that is discovering new treatments as well as better ways of applying existing treatments.

Among the goals of such innovation are:

• Finding ways to treat previously untreatable conditions
• Extending the lives of patients in terminal cases
• Reducing the side effects of treatment
• Discovering greater efficacy in combinations of different treatments

To make this possible requires not just lots of research, but a willingness of those carrying it out to share results and collaborate widely in what amounts to a global team effort to fight cancer in ever more effective ways.

What Is The Main Purpose of World Cancer Research Day?

Since World Cancer Research Day was established ten years ago by ten leading research bodies from around the world, every year has had a particular theme.

This time, the importance of collaboration is in the spotlight because it has such a role to play in advancing oncology.

Scientific director of the Scientific Foundation of the Spanish Association against Cancer Marta Puyol said its launch in 2016 aimed to “give cancer research the visibility and recognition it deserves”.

A decade on, she reflected, the growth of the day into a “global movement” is “a testament to the commitment of the many organisations and individuals who believe that research is essential to changing the future of cancer”.

Founder members of the event include Cancer Research UK, the European Association for Cancer Research, the American Association for Cancer Research and the International Agency for Research on Cancer.

They and the rest of the founding bodies were joined by several more organisations who have subsequently joined, including the European Organisation for Research and Treatment of Cancer (EORTC).

What Was Discussed At The World Cancer Research Day Conference?

EORTC was this year’s host of the annual conference to mark World Cancer Research Day, in Brussels on September 23^rd, which was held to highlight further the importance of global collaboration in research.

The amount of research taking place around the world is huge, although not all of it makes the wider news headlines.

What Are The Big Cancer Research Findings In 2026 Thus Far?

Even so, one may often read of new innovations and the research underpinning them that has improved cancer treatment. So far in 2026, there have been several examples.

• Research in Australia found that a cold laser treatment could completely eradicate early-stage prostate tumours in 84 per cent of cases
• A new prostate cancer treatment developed in the UK uses five stereotactic radiotherapy sessions rather than a more drawn-out series of 20, which NHS England believes will be more effective
• Another UK development has been a blood test that can be used to detect several different forms of cancer from one sample
• A personalised vaccine has been developed by Merck and Moderna that can prevent the return of high-risk melanoma after surgery
• A study in South Korea found that adjuvant radiotherapy after breast cancer surgery did not increase the risk of skin cancer in Korean women, in contrast with previous findings in Western countries indicating that it did

These are just some of the significant breakthroughs in discovering new treatments and assessing what works best when using established methods of fighting cancer.

As may be noted from the above list, the research has come from across the globe, involving many companies, universities and hospitals, with the research being published across the world.

For example, the research on the blood test, carried out by Queen Mary University of London, was published in the New England Journal of Medicine and Nature Medicine, both based in the US. The Korean research was published in the British Journal of Cancer.

Can Cancer Research In One Part Of The World Discover Something Missed Elsewhere?

International research of this kind can provide new data that, used in partnership with other studies elsewhere, can help to build up more comprehensive pictures of cancer conditions and the impacts of treatment.

The Korean research on adjuvant radiotherapy after breast cancer surgery is a prime case of how research in a different part of the world can spot something important that other studies have missed.

Its findings did not fully contradict those of western research, but drew attention to the fact that the risks of skin cancer arising from adjuvant radiotherapy are lower in populations with darker skin.

Racial factors are already known to produce many variables in cancer incidences, such as black men being the most vulnerable group to prostate cancer, while it is known that lighter skin increases vulnerability to melanoma.

How Can The Latest Cancer Research Be Used To Improve Personalised Cancer Care?

This latest discovery can further demonstrate how such characteristics can help to guide and tailor treatment programmes, ensuring that each individual gets the most appropriate treatment for them.

Such a finding is not to imply that adjuvant radiotherapy should not be used on breast cancer patients with lighter skin, as the risk remains lower than that of a recurrence of breast cancer, but it can be used to inform treatment decisions and aftercare.

This point is also important to bear in mind, as it highlights how we approach oncology. Personalised, tailored treatment is the best approach for every individual, rather than any formulaic approach. This will take into account various factors:

• Age
• General health
• How early the diagnosis has been made
• Whether metastasis has taken place
• The exact location of tumours
• Genetic and ethnic factors

These are just some of the considerations and, just as importantly, the consent of the patient is another central element of how we approach each case.

What collaboration in research does is help to advance oncology and enable more innovation, with the latest techniques and knowledge being brought to bear in our treatment of patients, resulting in better outcomes.

This means that the topics discussed in Brussels and the commitments made by research organisations around the globe will ultimately manifest in better treatments worldwide.